Geode Capital Management, LLC Codex Dna, Inc. Transaction History

Geode Capital Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	N/A	10,750 Added 14.76%	83,561 $154,000
Q4 2022 Feb 13, 2023	BUY	$1.12 - $1.69 $3,907 - $5,896	3,489 Added 5.03%	72,811 $91,000
Q3 2022 Nov 14, 2022	SELL	$1.7 - $2.36 $26,186 - $36,353	-15,404 Reduced 18.18%	69,322 $115,000
Q2 2022 Aug 12, 2022	SELL	$1.8 - $6.45 $116,044 - $415,825	-64,469 Reduced 43.21%	84,726 $152,000
Q1 2022 May 13, 2022	BUY	$4.12 - $10.36 $111,433 - $280,206	27,047 Added 22.14%	149,195 $801,000
Q4 2021 Feb 11, 2022	BUY	$6.31 - $11.96 $301,674 - $571,795	47,809 Added 64.31%	122,148 $1.32 Million
Q3 2021 Nov 12, 2021	BUY	$10.15 - $19.88 $609,923 - $1.19 Million	60,091 Added 421.75%	74,339 $827,000
Q2 2021 Aug 13, 2021	BUY	$17.76 - $22.0 $253,044 - $313,456	14,248 New	14,248 $313,000

307

Ticker DNAY
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 29,518,200
Market Cap $54.6M
Description
Codex DNA, Inc., a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide. Its solutions include BioXp system that empowers researchers to go from a digital DNA sequence to endpoint-ready synthetic DNA...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.